Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.
Niki Vora reflects on how her struggles with untreated atopic dermatitis, folliculitis and cystic acne led her to writing her scholarship-winning essay.
Are your patients happy with their current acne treatment? These five new therapeutic options could offer better results, according to several studies.
Refresh your memory on treatment guidelines for mild, moderate and severe acne in this easy-to-view slideshow.
Phase 3 studies suggest new topical retinoid effectively treats facial and truncal acne.
Cassiopea SpA submitted a New Drug Application (NDA) to the U.S. Federal Drug Administration (FDA) for its novel acne treatment, clascoterone cream 1%, according to a company announcement released today.
The U.S. Food and Drug Administration (FDA) accepted a new drug application (NDA) for Ortho Dermatologics’ novel tazarotene O.045% lotion (IDP-123) with a PDUFA action date of Dec. 22, 2019, according a recent announcement from the company.
There have been several shifts over time around beliefs in the association between diet and acne. Linda Stein Gold, M.D., discussed the recommendations of current guidelines at the summer meeting of the American Academy of Dermatology.
It’s no secret that antibiotics have been successful in controlling most acne cases, but the need to limit antibiotic use means acne treatment protocols are starting to shift. William James, M.D. emphasizes two alternatives dermatologists should turn to when treating patients with acne.
Traditional treatments remain important parts of the dermatologist's armamentarium for acne management, but other drugs have begun to play a role, too. Meanwhile, research is offering new insight into the causes of acne. Stay up to date on the latest insight into acne's pathogenesis, evaluation and treatment. Participate in this forum.